FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, particularly to an anti-WTA (teichoic acid conjugate) antibody-antibiotic for treating Staphylococcus aureus bacterial infection, as well as to a pharmaceutical composition containing it. Also disclosed a method of producing an anti-WTA antibody-antibiotic conjugate involving conjugation of an intermediate antibiotic linker with an anti-WTA antibody.
EFFECT: invention provides effective treatment of bacterial infection caused by Staphylococcus aureus.
23 cl, 22 dwg, 24 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS WITH RIFAMYCIN AND USE THEREOF | 2015 |
|
RU2731055C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2636780C1 |
| COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
| ANTI-PBP2A PROTEIN MONOCLONAL ANTIBODIES AND HOMOLOGOUS SEQUENCES FOR TREATING BACTERIAL INFECTION AND IMMUNODIAGNOSIS OF Firmicutes BACTERIA | 2010 |
|
RU2575070C2 |
| TREATMENT OF INFECTION CAUSED BY MICROORGANISMS | 2002 |
|
RU2303460C2 |
| ANTI-PTK7 ANTIBODY-DRUG CONJUGATES | 2015 |
|
RU2708075C2 |
| ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
| ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF | 2014 |
|
RU2656161C1 |
| ANTIBODIES AND IMMUNOCONJUGATES AND THEIR APPLICATIONS | 2007 |
|
RU2639543C9 |
| COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
